Ono Pharmaceutical (OTCMKTS:OPHLY) Shares Down 0.5%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLYGet Free Report) dropped 0.5% during mid-day trading on Friday . The company traded as low as $5.49 and last traded at $5.56. Approximately 97,060 shares traded hands during trading, an increase of 53% from the average daily volume of 63,337 shares. The stock had previously closed at $5.59.

Ono Pharmaceutical Stock Performance

The company’s 50-day moving average price is $5.86 and its 200-day moving average price is $6.06.

About Ono Pharmaceutical

(Get Free Report)

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.

Featured Articles

Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.